Immunomodulation using genetically engineered bacteria for type III-mediated delivery of heterologous antigens and cytokines: Potential application in vaccine and therapeutical developments
2009 ◽
Vol 00
(00)
◽
pp. 090924084723050-4
2010 ◽
Vol 32
(1)
◽
pp. 1-4
◽
1990 ◽
pp. 243-250
◽
2020 ◽
pp. 331-350
◽
1992 ◽
Vol 174
(9)
◽
pp. 2978-2985
◽
1983 ◽
Vol 413
(1 Biochemical E)
◽
pp. 23-30
◽
2001 ◽
Vol 76
(2)
◽
pp. 126-131
◽